Followers | 184 |
Posts | 4438 |
Boards Moderated | 2 |
Alias Born | 01/08/2018 |
Saturday, February 29, 2020 5:01:55 PM
TREP plaintiff, IRS defendant.
True IRS issue has existed for a long LONG time but this is where statue of limitation come into play.
They've recently been vocal about it legally in PRs at shareholders request.
The company is working with counsel to resolve all past tax issues in the best interest of shareholders and clients
https://www.otcmarkets.com/stock/TREP/news/Trucept-Inc-Provides-Corporate-Update-and-Year-End-Summary?id=219610
Trucept CEO Norman Tipton said disputed liabilities, identified on its financials, "have been by resolved $2 million, and we anticipate resolving more through 2019."
https://www.otcmarkets.com/stock/TREP/news/Trucept-Releases-Year-End-2018?id=219983
Trucept CEO Norman Tipton said the increase in Net Income is attributable to the settlement of outstanding debt. "In 2017
https://www.otcmarkets.com/stock/TREP/news/Trucept-Publishes-First-Quarter-2019?id=229585
Trucept continues to negotiate disputed liabilities and has successfully reduced them by approximately $2.6 million, for a net income increase of about 37 percent from the previous quarter
https://www.otcmarkets.com/stock/TREP/news/Trucept-Publishes-Second-Quarter-2019-Earnings?id=237680
'MR1906'
AGREE!!
Look at the increase in growth in the last 2 years
https://www.otcmarkets.com/stock/TREP/news
Once TREP wins that $18.9M and get it knocked off the liabilities. They'll have a near clean balance sheet.
How much more years do they need to prove they can build shareholders value?
7 years the company has grown bigger each year
7 years no convertible notes
7 years near untouched share structure
Can we put a price on that?
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM